Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Protein-protein interactions as a basis for drug t

A membrane-based two-hybrid system enables the identification of novel interacting partners of membrane proteins, and the high-throughput screening of small molecules that inhibit a given protein-protein interaction.

Igor Stagljar, Michael Hottiger, Daniel Auerbach a (December 2001)

Keywords: biopharm, bioreactor, genetic engineering, microbial, cell culture, cell separation, genetics, genomics, biosensors, molecular biology, microbiological testing, microbiology, protein engineering, oligonucleotides, collaboration, biotech research, company news, events, biomedical, industry, government, life sciences, education, investor, publications, medicine, medical, genes, genetic, engineering, recombinant, cell therapy, microbiology, pharmacology, sequencing, bioengineering, chromosome, genetics, protein, CAT, galactosidase, NPT, immunofluorescense, antibody, chromatography, filtration, nucleotide, m13, lambda, instaprep, perfectprep, bigprep, PerfectRNA, subventions,

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |